CCNYSEChemicals & Allied ProductsFiscal year ends December 31
Chemours Co
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$12.62−0.12 (-0.94%)
Close on Oct 19, 2026
- Market cap
- $1.91B
- P/E (TTM)
- –
- Dividend yield
- 4.06%
Share price
−$0.28 (−2.17%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.EarningsEx-dividend
Chemours Co saw revenue fall 0.9% to $5.80B over the twelve months to Jun 30, 2026. Free cash flow was $218.00M.
Revenue
$5.80B
-0.9% vs. a year earlier
Free cash flow
$218.00M
TTM Q2 2026
EPS, diluted
-$2.00
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $1.91B
- P/E ratio
- –
- Price to sales
- 0.33
- Price to book
- –
- Dividend yield
- 4.06%
- Free cash flow yield
- 11.42%
Fundamentals
- Revenue
- $5.80B
- Net income
- -$304.00M
- EPS, diluted
- -$2.00
- Free cash flow
- $218.00M
- Book value per share
- -$0.32
- Diluted shares
- 151M
Thirteen years at a glance
Fiscal years 2013 to 2025 and trailing twelve months, USD
Revenue
$5.80B-0.9% YoY
Gross profit
$887.00M-16.7% YoY
Net income
-$304.00M
EPS, diluted
-$2.00
Free cash flow
$218.00M
Reported periodTrailing twelve months